Status:
UNKNOWN
The Use of a Quality of Life Questionnaire in Patients With Lung Cancer
Lead Sponsor:
Royal Marsden NHS Foundation Trust
Conditions:
Lung Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study will investigate the effectiveness of using the European Organisation for Research and Treatment of cancer Core Quality of Life Questionnaire (EORTC QLQ-C30 + LC 13) to identify and target ...
Detailed Description
Patients with lung cancer who have completed a course of treatment (or who are in-between treatment) at the Royal Marsden Hospital would be eligible for inclusion in the study. Participants will be ra...
Eligibility Criteria
Inclusion
- male or female age \> 18 years
- patients who are able to adequately understand written and spoken english
- diagnosis of lung cancer (non small cell, small cell, mesothelioma)
- no plan to commence treatment (chemotheraphy, targeted therapies, radioterhapy, surgery) with 6 weeks
- both radically or palliatively treated patients remain eligible
- patients whose toxicities from their primary treatment has resolved or have stabilised for a period of 7 days
Exclusion
- patients are taking part on any other QoL studies
- taking part in any other studies that requires QoL questionnaires, extra visits or investigations
- currently on treatment (chemotherapy, radiotherapy, surgery or targeted therapies)
- they have on going toxicities from their treatment which have not been stablised (required intervention within last 7 days)
Key Trial Info
Start Date :
September 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2012
Estimated Enrollment :
138 Patients enrolled
Trial Details
Trial ID
NCT01213745
Start Date
September 1 2010
End Date
July 1 2012
Last Update
October 21 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Marsden NHS Foundation Trust
Sutton, United Kingdom, SM2 5PT